Aurobindo Pharma Fundamental Analysis and Financial Ratios

Description
The Model covers all the major fundamental aspects of the company over a few years period. The model is easy to edit and update for the future years as well when the company releases its new annual report. The fundamental analysis includes formula based excel model and visualizations of the following:

1. Growth Ratios
2. Profitability Ratios
3. Cash Flow Ratios
4. Liquidity and Solvency Ratios
5. Efficiency Ratios
6. Valuation Multiples (EV/EBIT, Market Cap/EBIT and EV/EBITDA)
7. ROE (Du Pont Analysis)
8. Common Size analysis
9. Enterprise Valuation
10. Financial Strength Analysis

About the company:

A fully integrated pharma company, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues. Aurobindo exports to over 150 countries across the globe with more than 90% of its revenues derived from international operations. Leveraging India’s globally competitive cost base and talented team of scientists, they have successfully launched a range of affordable products which are accessible across the globe. From discovery to development to commercialization, our growth is aided by cost-effective drug development and substantial manufacturing.

The aim is to provide a thorough outlook into the company's financial position. This will help you in projects as well as learning fundamental analysis on their own. This can also be used by Investors who are looking to do their own due diligence before investing in the Indian Stock Markets

(Note: All the research done by us is only for educational purposes and should not be seen as Investment recommendations. We are not SEBI registered Investment Advisors)